The effect of enamel matrix derivative (Emdogain®) on gene expression profiles of human primary alveolar bone cells. (11th June 2012)

• Record Type: Journal Article
• Authors: Yan, X. Z.; Rathe, F.; Gilissen, C.; van der Zande, M.; Veltman, J.; Junker, R.; Yang, F.; Jansen, J. A.; Walboomers, X. F.
• Is Part Of: Journal of tissue engineering and regenerative medicine. Volume 8:Number 6(2014:Jun.)
• Page Start: 463
• Page End: 472
• Publication Date: 2012-06-11
• Subjects: Tissue engineering -- Periodicals; Regeneration (Biology) -- Periodicals; 610.28
• DOI: 10.1002/term.1545
• Languages: English
• ISSNs: 1932-6254

Abstract

<abstract abstract-type="main"> <title>Abstract</title> <p>Emdogain® is frequently used in regenerative periodontal treatment. Understanding its effect on gene expression of bone cells would enable new products and pathways promoting bone formation to be established. The aim of the study was to analyse the effect of Emdogain® on expression profiles of human‐derived bone cells with the help of the micro‐array, and subsequent validation. Bone was harvested from non‐smoking patients during dental implant surgery. After outgrowth, cells were cultured until subconfluence, treated for 24 h with either Emdogain® (100 µg/ml) or control medium, and subsequently RNA was isolated and micro‐array was performed. The most important genes demonstrated by micro‐array data were confirmed by qPCR and ELISA tests. Emdogain tipped the balance between genes expressed for bone formation and bone resorption towards a more anabolic effect, by interaction of the PGE<sub>2</sub> pathway and inhibition of IL‐7 production. In addition the results of the present study indicate that Emdogain possibly has an effect on gene expression for extracellular matrix formation of human bone cells, in particular on bone matrix formation and on proliferation and differentiation. With the micro‐array and the subsequent validation, the genes possibly involved in Emdogain action on bone cells were identified. These results can contribute to establishing new products and pathways promoting bone formation. Copyright © 2012 John Wiley & Sons, Ltd.</p> </abstract>